共 54 条
[1]
EFFECT OF POLICOSANOL IN LOWERING CHOLESTEROL LEVELS IN PATIENTS WITH TYPE-II HYPERCHOLESTEROLEMIA
[J].
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL,
1995, 56 (02)
:176-182
[2]
EFFECT OF SUCCESSIVE DOSE INCREASES OF POLICOSANOL ON THE LIPID PROFILE AND TOLERABILITY OF TREATMENT
[J].
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL,
1993, 54 (03)
:304-312
[3]
Arruzazabala M L, 1994, Biol Res, V27, P205
[6]
LOVASTATIN INHIBITS LOW-DENSITY-LIPOPROTEIN OXIDATION AND ALTERS ITS FLUIDITY AND UPTAKE BY MACROPHAGES - INVITRO AND INVIVO STUDIES
[J].
METABOLISM-CLINICAL AND EXPERIMENTAL,
1992, 41 (03)
:229-235
[7]
BONNE C, 1989, ARZNEIMITTEL-FORSCH, V39-2, P1242
[8]
CANETTI M, 1995, ADV THER, V12, P245
[9]
ONE-YEAR STUDY OF THE EFFICACY AND SAFETY OF POLICOSANOL (5 MG TWICE-DAILY) IN THE TREATMENT OF TYPE-II HYPERCHOLESTEROLEMIA
[J].
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL,
1995, 56 (03)
:296-304
[10]
CHAPMAN MJ, 1980, J LIPID RES, V21, P789